Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriem Boufraqech

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2010
Functional consequences of dual oxidase-thyroperoxidase interaction at the plasma membraneRodrigo Soares Fortunato, Elaine Cristina Lima de Souza, Rabii Ameziane-el Hassani, et al.
Oncotarget|May 6, 2015
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancerLisa Zhang, Yaqin Zhang, Amit Mehta, et al.
Thyroid : Official Journal of the American Thyroid Association|November 7, 2018
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer AggressivenessMyriem Boufraqech, Dhaval Patel, Naris Nilubol, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid CancerShawn Noronha, Yue Liu, Gaga Geneti, et al.
Molecular Carcinogenesis|April 26, 2026
CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid CancerShawn Noronha, Yue Liu, Gaga Geneti, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2010
Functional consequences of dual oxidase-thyroperoxidase interaction at the plasma membraneRodrigo Soares Fortunato, Elaine Cristina Lima de Souza, Rabii Ameziane-el Hassani, et al.
Oncotarget|May 6, 2015
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancerLisa Zhang, Yaqin Zhang, Amit Mehta, et al.
Thyroid : Official Journal of the American Thyroid Association|November 7, 2018
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer AggressivenessMyriem Boufraqech, Dhaval Patel, Naris Nilubol, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid CancerShawn Noronha, Yue Liu, Gaga Geneti, et al.
Molecular Carcinogenesis|April 26, 2026
CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid CancerShawn Noronha, Yue Liu, Gaga Geneti, et al.
Pageof 5